The framework tracks subclonal lineages on locally finite rooted ordered trees, maps each genotype to a phenotype drawn from five functional classes (proliferation deregulation, mutation burden, limit evasion, resource control, null), and evolves populations via size-dependent birth-death processes with phenotype-dependent parameters; appearance of new genotypes follows a Cox process, and simulation uses an Ξ΅-leaping-like multinomial scheme with a studied timestep error bound. An open-source Next.js GUI produces Muller plots, trees, and synthetic VCFs [citation doi="" title="" research-extract="" url="" number-citations="" descriptive-anchor-text="" evidence-strength=""]
The key biological claim is a biphasic regime: early growth is dominated by stochastic expansion (proliferative drivers barely shift clonal dynamics), whereas after carrying-capacity saturation only limit-evasion and resource-control mutations permit further expansion. Notably, neutral and purely proliferative regimes generate nearly identical clonal architectures, supporting the authors' caution that (n, D) patterns alone cannot distinguish neutral from selected evolution β echoing the 2018 neutral-evolution controversy they cite.
Using (clonal nesting n, clonal diversity D) indices from 7 studies spanning 6 tumor types (AML, ccRCC, mesothelioma, breast, NSCLC, uveal melanoma), the authors fit parameters via KDE-based likelihood over 100 simulations per configuration. The liquid-vs-solid split is the strongest result: AML is best explained by pure proliferative advantage with carrying capacity above detection size, while all solid tumors require carrying capacity below detection size plus limit-evasion or resource-control mechanisms [citation doi="" title="" research-extract="" url="" number-citations="" descriptive-anchor-text="" evidence-strength=""]
Confidence: moderate-high on the mathematical construction and reported simulation behavior; moderate on the biological conclusions, which rest on summary-statistic fitting without prospective falsification. The authors explicitly disclaim a "new evolutionary paradigm," which is honest β the contribution is unification and tooling, not new biology.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.